Anatara’s Chairman Mel Bridges conducted an interview recently with the Australian Associated Press which published an article that was widely reproduced across many media outlets.

The article highlighted that Anatara was raising $7 million in an initial public offering and would list on the Australian Securities Exchange.

It noted that Anatara’s lead product, DetachTM is a non-antibiotic medicine made from an extract from pineapple roots to treat and prevent diarrhoea in food production animals and planned to be first used in pigs.

The article was published on numerous widely-read news websites including The Australian, The Age, The Sydney Morning Herald, The Herald Sun, and The Daily Telegraph.